WeVote
Log In

Bill

Bill

HB 1548

Consumer Protection Act; exempt certain pharmaceutical distributors from.

2025 Regular Session Introduced by Manly Barton

Failed Mississippi bill would have exempted certain pharmaceutical distributors from consumer protection regulations, potentially reducing accountability in drug supply chains.

Died In Committee
#businessandcommerce
0
WeVote Research Nonpartisan
Bill Summary · HB 1548

Legislative bill overview

HB 1548 would have exempted certain pharmaceutical distributors from consumer protection regulations in Mississippi. The bill was referred to the Business and Commerce Committee in January 2025 but died in committee by early February, meaning it did not advance for a floor vote.

Why is this important

Pharmaceutical distribution is a critical link in the drug supply chain affecting medication access and safety for Mississippi residents. Exemptions from consumer protection laws could impact consumers' ability to seek recourse for issues like counterfeit drugs, pricing disputes, or delivery failures.

Potential points of contention

  • Consumer safeguards: Exempting distributors from consumer protections may reduce accountability for product quality, safety, or fair dealing
  • Market competition: Selective exemptions could unfairly advantage certain distributors over competitors still bound by regulations
  • Public health concerns: Weakened oversight of pharmaceutical distribution could create vulnerabilities in drug supply chain integrity and authenticity verification

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.